The US preventive services task force should consider a broader evidence base in updating its diabetes screening guidelines

Health Affairs

Volumn 31, Issue 1, 2012, Pages 35-42

  Villarivera, Christel ^a   Wolcott, Julie ^b   Jain, Anjali ^a   Zhang, Yiduo ^c   Goodman, Clifford ^a  

^a Lewin Group   (United States)

^b Medimmune ^*

^c MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PLACEBO;

ARTICLE; CARDIOVASCULAR RISK; CONCEPTUAL FRAMEWORK; DIABETIC PATIENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MEDICAL PRACTICE; MEDICAL SOCIETY; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING; UNITED STATES; ADVISORY COMMITTEE; EVIDENCE BASED MEDICINE;

ADVISORY COMMITTEES; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; UNITED STATES;

EID: 84855682136     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0953     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 [Internet]. Atlanta (GA): CDC; 2011 [cited 2011 Dec 7]. Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf
2. American Diabetes Association. Diabetes statistics [Internet]. Alexandria (VA): ADA; [cited 2011 Dec 7]. Available from: http://www.diabetes.org/diabetes-basics/diabetes-statistics/
3. American Diabetes Association. Direct and indirect costs of diabetes in the United States [Internet]. Alexandria (VA): ADA; [cited 2011 Dec 7]. Available from: http://www.diabetesarchive.net/diabetesstatistics/cost-of-diabetes-in-us.jsp
4. Dall TM, Zhang Y, Chen J, Quick WW, YangWG, Fogli J. The economic burden of diabetes. Circulation. 2010;29(2):1-6.
5. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753-9.
6. Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care. 2007; 30(2):228-33.
7. Lesser LI, Krist AH, Kamerow DB, Bazemore AW. Comparison between US Preventive Services Task Force recommendations and Medicare coverage. Ann Fam Med. 2011;9(1): 44-9.
8. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011;34(Suppl 1):S11-61.
9. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract. 2011;17(2):287-302.
10. Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for the management of diabetes mellitus. Washington (DC): VA, DoD; 2010 Aug.
11. Kaiser Permanente Care Management Institute. Adult diabetes clinical practice guidelines. Oakland (CA): The Institute; 2006.
12. Feig DS, Palda VA, Lipscombe L, Canadian Task Force on Preventive Health Care. Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care. CMAJ. 2005;172(2):177-80.
13. Ratner RE, Sathasivam A. Treatment recommendations for prediabetes. Med Clin North Am. 2011;95(2): 385-95, viii-ix.
14. US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 148(11):846-54.
15. Sheehy AM, Flood GE, Tuan WJ, Liou JI, Coursin DB, Smith MA. Analysis of guidelines for screening diabetes mellitus in an ambulatory population. Mayo Clin Proc. 2010; 85(1):27-35.
16. To access the Appendix, click on the Appendix link in the box to the right of the article online.
17. Mau MK, Sinclair K, Saito EP, Baumhofer KN, Kaholokula JK. Cardiometabolic health disparities in native Hawaiians and other Pacific Islanders. Epidemiol Rev. 2009;31: 113-29.
18. Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet. 2010;375(9723):1365-74.
19. Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003; 26(11):3093-101.
20. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol. 2006;163(11):1042-52.
21. US Preventive Services Task Force. Screening for obesity in adults: recommendations and rationale [Internet]. Rockville (MD): USPSTF; 2003 Nov [cited 2011 Dec 7]. Available from: http://www.uspreventiveservicestaskforce.org/3rduspstf/obesity/obesrr.htm
22. Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, et al. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study-secondary analysis of the randomized trial. PLoS One. 2009;4(5):e5656.
23. Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia. 2008;51(2):249-57.
24. Skriver MV, Borch-Johnsen K, Lauritzen T, Sandbaek A. HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark. Diabetologia. 2010; 53(11):2328-33.
25. Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17): 1566-75.
26. Padwal RS, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev. 2004;(3):CD004094.
27. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009; (2):CD003641.
28. Groeneveld IF, Proper KI, van der Beek AJ, Hildebrandt VH, van Mechelen W. Factors associated with non-participation and drop-out in a lifestyle intervention for workers with an elevated risk of cardiovascular disease. Int J Behav Nutr Phys Act. 2009;6:80.
29. Graham GN, Leath B, Payne K, Guendelman M, Reynolds G, Kim S, et al. Perceived versus actual risk for hypertension and diabetes in the African American community. Health Promot Pract. 2006;7(1): 34-46.
30. Norris SL, Kansagara D, Bougatsos C, Fu R. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008; 148(11):855-68.
31. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6): 393-403.
32. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702): 1677-86.
33. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr., Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-59.
34. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular out-comes in patients with type 2 diabetes. N Engl J Med. 2008;358: 2560-72.
35. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360: 129-39.